2021 Annual Meeting

Session: Crystallization Process Development

Chair

Green, D., GlaxoSmithKline

Presentations

08:03 AM

(568a) Cephalexin and Amoxicillin Crystal Shape Modification By Manipulating the Supersaturation and Wet Milling

08:24 AM

(568b) Accelerated Early-Stage Enabling API Crystallization Process Development and Scale-up

08:45 AM

(568c) Development and Scale-up of a Crystallization Process for a Kinetically-Unfavorable Polymorph

09:27 AM

(568e) Acid-Catalyzed Esterification Governs the Chain Elongation and the Oriented Attachment in Cof-5 Synthesis

09:48 AM

(568f) Enabling a Selective Dissolution Scheme for the Removal of Fines in Crystallization with a Hydrocyclone: Modeling and Experimental Validation

10:09 AM

(568g) Crystallization Modeling of a Pharmaceutical Compound for Digital Twin Based in-Silico Optimization with Experimental Validation